| Date Filed | Type | Description |
| 10/05/2023 |
8-K
| Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce... |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/10/2023 |
8-K
| Resignation/termination of a director |
| 06/30/2023 |
SC 13D/A
| MANCHESTER MANAGEMENT CO LLC reports a 15.7% stake in Modular Medical, Inc. |
| 05/17/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"UNDERWRITING AGREEMENT",
"OPINION OF LUCOSKY BROOKMAN LLP",
"Modular Medical Announces Pricing of Upsized $9.4 Million Public Offering SAN DIEGO, CA / ACCESSWIRE / May 16, 2023 / Modular Medical, Inc. , a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced the pricing of an upsized underwritten public offering of 8,816,900 shares of its common stock and warrants to purchase 4,408,450 shares of its common stock. The securities are being sold as a unit, with each unit comprising two shares of common stock and one warrant to purchase one share of common stock. The units are being sold at a combined price to the public of $2.13 per unit, yielding an effective price of $1.06 per share and $0.01 per warrant. The warrants will be exercisable at $1..." |
|
| 05/17/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 05/17/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/16/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 05/16/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/05/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 04/24/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 02/13/2023 |
10-Q
| Quarterly Report for the period ended December 31, 2022 |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/19/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits Interactive Data |
| 01/11/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 12/20/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 11/16/2022 |
10-Q/A
| Quarterly Report for the period ended September 30, 2022 [amend] |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 08/11/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/26/2022 |
8-K
| Quarterly results |
| 07/22/2022 |
8-K
| Quarterly results |
| 07/08/2022 |
424B1
| Form 424B1 - Prospectus [Rule 424(b)(1)]: |
| 07/08/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/06/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 06/28/2022 |
10-K
| Annual Report for the period ended March 31, 2022 |
| 06/13/2022 |
8-K
| Quarterly results |
| 06/06/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 05/05/2022 |
8-K
| Quarterly results |
| 05/04/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 04/15/2022 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 04/08/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 04/08/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 02/28/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/25/2022 |
8-K
| Quarterly results |
|